MARY LAIRD: Open Payments
NPI 1881133114 · CHAMPAIGN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 26 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $143 |
| Biogen, Inc. | 6 | $106 |
| Exact Sciences Corporation | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Organon LLC | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $25 |
Products named: Veozah, ZURZUVAE, NEXPLANON, INJECTAFER, Cologuard Collection Kit, MYFEMBREE, UBRELVY, The Cologuard Plus Collection Kit.
Industry payments across IL — which companies pay providers there.
